{
  "@context": "https://schema.org/",
  "@type": "Dataset",
  "id": "nutrient:alpha-lipoic-acid:diabetic-neuropathy:v1",
  "title": "Alpha Lipoic Acid \u2014 Diabetic Neuropathy",
  "category": "metabolic",
  "intervention_type": "supplement",
  "tier": "Silver",
  "label": "PASS",
  "P_effect_gt_delta": 0.72,
  "gate_results": {
    "phi": "PASS",
    "r": 0.85,
    "j": 0.78,
    "k": "PASS",
    "l": "PASS"
  },
  "evidence_summary": {
    "n_studies": 2,
    "total_n": 310,
    "I2": 25.3,
    "tau2": 0.04,
    "mu_hat": 0.31,
    "mu_CI95": [
      0.18,
      0.44
    ],
    "design_breakdown": {
      "RCT": 2,
      "cohort": 0,
      "other": 0
    }
  },
  "policy_refs": {
    "tel5_levels": "v1.2.0",
    "monte_carlo": "v1.0.1-reml-grid",
    "journal_trust": "2025-10-05"
  },
  "version": "v1",
  "audit_hash": "0xca2423ba030ebf5b",
  "policy_fingerprint": "0x4d3c2b1a0f9e8d7c",
  "citations_manifest_hash": "sha256:a98d7d482872d05153143fe812235d8e6bd9388058edf1b7c1b17b8054873ccd",
  "tier_label_system": "TEL-5"
}